Cigarette smoking has a differential effect on the plasma level of clozapine in Taiwanese schizophrenic patients associated with the CYP1A2 gene −163A/C single nucleotide polymorphism
Authors:
- Hui-Ching HuangHHHui-Ching Huang
- Ahai Chang LuaALAhai Chang Lua
- Lawrence Shih-Hsin WuLWLawrence Shih-Hsin Wu
- Bo-Jian WuBWBo-Jian Wu
- Shin-Min LeeSLShin-Min Lee
- Chao-Zong LiuCLChao-Zong Liu
- 1 August 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Psychiatric Genetics
- Vol. 26 (4) , 172-177
Abstract
The efficacy of clozapine clearance has been shown to be associated with smoking and genetic polymorphism of CYP1A2. This study aims to investigate the effect of smoking on the plasma level of clozapine in Taiwanese schizophrenic patients and its relevance to the CYP1A2 gene −163A/C single nucleotide polymorphism. A total of 143 hospitalized schizophrenic patients who had received clozapine therapy for at least 14 days were enrolled in this study. The trough plasma concentration of clozapine was measured with LC/MS/MS. The −163A/C variant in the CYP1A2 gene was identified by DNA sequencing and restriction fragment length polymorphism analysis. The effect of smoking on the clozapine level was examined by multiple linear regression analysis and its relation to the −163A/C variant of the CYP1A2 gene was analyzed using a general linear model with Bonferroni correction. Patients with smoking habits showed a significantly lower plasma level of clozapine than those without smoking habits (P=0.022) and the difference in clozapine levels between smokers and nonsmokers appeared to be significant in the individuals carrying the homozygous −163A allele (P=0.02). It was also found that nonsmokers carrying the −163A allele tended to have higher plasma levels of clozapine. This tendency was not found in the individuals with smoking habits. Cigarette smoking has a significant impact on the plasma level of clozapine in Taiwanese schizophrenic patients carrying the homozygous −163A allele in the CYP1A2 gene. Cigarette smoking may increase the clearance of clozapine in these patients.Keywords
This publication has 38 references indexed in Scilit:
- Increased Clozapine Plasma Concentrations and Side Effects Induced by Smoking Cessation in 2 CYP1A2 Genotyped PatientsTherapeutic Drug Monitoring, 2005
- The Dosing of Atypical AntipsychoticsPsychosomatics, 2005
- Nonresponse to Clozapine and Ultrarapid CYP1A2 ActivityJournal of Clinical Psychopharmacology, 2004
- CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patientsEuropean Journal of Pharmaceutical Sciences, 2003
- Evidence from a population pharmacokinetics analysis for a major effect of CYP1A2 activity on inter- and intraindividual variations of clozapine clearanceProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2002
- Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.Journal of Pharmaceutical and Biomedical Analysis, 2001
- A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophreniaMolecular Psychiatry, 2000
- Cytochrome P450 and therapeutic drug monitoring with respect to clozapineEuropean Neuropsychopharmacology, 1999
- Very High Cytochrome P4501A2 Activity and Nonresponse to ClozapineArchives of General Psychiatry, 1998
- Drug Interactions and the Cytochrome P450 SystemClinical Pharmacokinetics, 1995